P615: BCL2 RESISTANCE MUTATIONS IN A REAL-WORLD COHORT OF PATIENTS WITH VENETOCLAX-TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA

P615: BCL2 RESISTANCE MUTATIONS IN A REAL-WORLD COHORT OF PATIENTS WITH VENETOCLAX-TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA

Bibliographic Details
Main Authors:	L. Kotmayer, T. László, R. Kiss, L. L. Hegyi, G. Mikala, P. Farkas, A. Balogh, T. Masszi, J. Demeter, J. Weisinger, H. Alizadeh, L. Gergely, A. Sulák, M. Egyed, M. Plander, P. Pettendi, D. Lévai, T. Schneider, Z. Pauker, A. Masszi, R. Szász, C. Bödör, D. Alpár
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845348.59055.24

Similar Items

Landscape of <i>BCL2</i> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
by: Lili Kotmayer, et al.
Published: (2023-03-01)

Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma
by: Ákos Nagy, et al.
Published: (2020-07-01)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
by: Ferenc Takács, et al.
Published: (2022-09-01)

PB1909: LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION
by: Tamás László, et al.
Published: (2023-08-01)

Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
by: Tamás László, et al.
Published: (2024-01-01)

P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
by: Bence Bátai, et al.
Published: (2023-08-01)

Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia
by: Donát Alpár, et al.
Published: (2021-11-01)

21H.615 The Middle East in 20th Century, Spring 2003
by: Russell, Mona L., et al.
Published: (2003)

Sistem Pengendali Mesin Tenun GA615
by: Dwi Cahyo Mahardika, et al.
Published: (2016-10-01)

ADW 615 - ADVANCED BUSINESS STATISTICS APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW 615 - ADVANCED BUNISESS STATISTICS APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW615 - ADVANCED BUSINESS STATISTICS - FEBRUARI 1998.
by: PPP, Pusat Pengajian Pengurusan
Published: (1998)

AGW615 - Advanced Business Statistics - February 2000
by: PPP, Pusat Pengajian Pengurusan
Published: (2000)

Study of the satellite navigation system OEM615's accuracy characteristics in various modes
by: Vlasov A. V., et al.
Published: (2015-12-01)

Familial multiple myeloma. Two more families
by: Várkonyi Judit, et al.
Published: (2009-12-01)

Discussion - G. T. Houlsby (2004). Geotechnique 54, No. 10, 615
by: Dean, E, et al.
Published: (2005)

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
by: Andrea Ceglédi, et al.
Published: (2023-11-01)

Ocular toxoplasmosis during frontline venetoclax therapy for chronic lymphocytic leukaemia – more than meets the eye
by: Rory Bennett, et al.
Published: (2023-05-01)

Sweet Syndrome in a Patient with Acute Leukemia on Azacitidine and Venetoclax Treatment
by: Rezmuves Maria Gabriela, et al.
Published: (2023-09-01)

The political ecology of late South American pastoralism: an Andean perspective A.D. 1,000-1,615
by: Jennifer L. Grant, et al.
Published: (2018-10-01)

Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance
by: Gergely Peskó, et al.
Published: (2019-12-01)

Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption
by: Judit Demeter, et al.
Published: (2021-02-01)

Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous protein.
by: Yasuhiro Miyamoto, et al.
Published: (2014-01-01)

P308: NOVEL COPY NUMBER ABERRATION-BASED CLASSIFICATION METHODS REFINE RISK ASSESSMENT IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: G. Bedics, et al.
Published: (2022-06-01)

Encuesta de parásitos intestinales en 615 escolares del Rímac
by: Luis Gonzales-Mugaburu
Published: (1956-12-01)

615 Reactivating antitumor immunity in gliomas with osteopontin/integrin blocking peptide
by: Bozena Kaminska, et al.
Published: (2021-11-01)

A Study On The Relationship Between Self-Esteem And Academic Achievement Of Iranian Students [BF697.5.S46 H615 2006H615 2006 ff rbrb].
by: Fathi, Heydar
Published: (2006)

615 A pilot study to implement the Type 1 & 2 SLE Model into clinical care
by: David S Pisetsky, et al.
Published: (2022-12-01)

Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis
by: Daniella Nagy, et al.
Published: (2022-07-01)

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content
by: Ákos Nádasdi, et al.
Published: (2023-03-01)

Development of venetoclax for therapy of lymphoid malignancies
by: Zhu H, et al.
Published: (2017-03-01)

PB2104: SOLUBLE B-CELL MATURATION ANTIGEN AS A MONITORING MARKER FOR MULTIPLE MYELOMA
by: Ádám Wiedemann, et al.
Published: (2023-08-01)

Specific O-GlcNAc modification at Ser-615 modulates eNOS function
by: Kulwant S. Aulak, et al.
Published: (2020-09-01)

P615: Congenital anemias in nonimmune hydrops fetalis diagnosed by exome sequencing
by: Mona Makhamreh, et al.
Published: (2023-01-01)

Soldadura del acero ASTM 615 con diferentes tipos de electrodos
by: Gioelkis Espinosa-Batista, et al.
Published: (2022-05-01)

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006
by: Shen Zhi-Xiang, et al.
Published: (2010-03-01)

In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation
by: Masashi Yanaki MD, et al.
Published: (2018-09-01)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
by: Paul J. Hampel, et al.
Published: (2021-03-01)

Potential mechanisms of resistance to venetoclax and strategies to circumvent it
by: Stephen K. Tahir, et al.
Published: (2017-06-01)

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma
by: Ádám Wiedemann, et al.
Published: (2023-04-01)